JNJ

170.71

-0.01%↓

ABBV

196.37

-1.09%↓

AZN

73.59

-1.13%↓

NVS

113.55

-3.58%↓

ABT

130.95

+0.14%↑

JNJ

170.71

-0.01%↓

ABBV

196.37

-1.09%↓

AZN

73.59

-1.13%↓

NVS

113.55

-3.58%↓

ABT

130.95

+0.14%↑

JNJ

170.71

-0.01%↓

ABBV

196.37

-1.09%↓

AZN

73.59

-1.13%↓

NVS

113.55

-3.58%↓

ABT

130.95

+0.14%↑

JNJ

170.71

-0.01%↓

ABBV

196.37

-1.09%↓

AZN

73.59

-1.13%↓

NVS

113.55

-3.58%↓

ABT

130.95

+0.14%↑

JNJ

170.71

-0.01%↓

ABBV

196.37

-1.09%↓

AZN

73.59

-1.13%↓

NVS

113.55

-3.58%↓

ABT

130.95

+0.14%↑

Search

Phreesia Inc

Closed

SectorHealthcare

27.09 0.11

Overview

Share price change

24h

Current

Min

26.8

Max

28.27

Key metrics

By Trading Economics

Income

2.5M

-3.9M

Sales

6.3M

116M

Profit margin

-3.376

Employees

2,082

EBITDA

2M

4.1M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+17.3% upside

Dividends

By Dow Jones

Next Earnings

3 Sept 2025

Market Stats

By TradingEconomics

Market Cap

193M

1.6B

Previous open

26.98

Previous close

27.09

News Sentiment

By Acuity

29%

71%

76 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Neutral Evidence

Phreesia Inc Chart

Past performance is not a reliable indicator of future results.

Related News

6 Aug 2025, 22:24 UTC

Earnings
Major Market Movers

Airbnb Logs 2Q Beat, But Investments Weigh on Margin Outlook -- Update

6 Aug 2025, 23:43 UTC

Market Talk

Nikkei May Decline Amid Uncertainty Over Earnings, U.S. Tariffs -- Market Talk

6 Aug 2025, 23:39 UTC

Market Talk

Gold Steady as Traders Assess Geopolitical, Tariff Developments -- Market Talk

6 Aug 2025, 23:28 UTC

Earnings

Kakao 2Q Net Profit Beat FactSet-Compiled Consensus

6 Aug 2025, 23:28 UTC

Earnings

Kakao 2Q Net KRW171.82B Vs. Net KRW87.15B >035720.SE

6 Aug 2025, 23:28 UTC

Earnings

Kakao 2Q Oper Pft KRW185.93B Vs. Pft KRW133.96B >035720.SE

6 Aug 2025, 23:28 UTC

Earnings

Kakao 2Q Rev KRW2.028T Vs. KRW2.005T >035720.SE

6 Aug 2025, 23:14 UTC

Earnings

Fiserv, Shift4, Toast Stocks Tumble on Earnings. Analysts Are Optimistic Anyway. -- Barrons.com

6 Aug 2025, 23:01 UTC

Earnings

United Overseas Bank 2Q Net Interest Income S$2.34B Vs. S$2.40B >U11.SG

6 Aug 2025, 23:01 UTC

Earnings

United Overseas Bank 2Q Total Income S$3.47B Vs. S$3.48B >U11.SG

6 Aug 2025, 23:00 UTC

Earnings

United Overseas Bank 2Q Net S$1.34B Vs. Net S$1.43B >U11.SG

6 Aug 2025, 22:54 UTC

Market Talk

New Zealand Companies Should Avoid Qualifying Profit Improvement -- Market Talk

6 Aug 2025, 22:41 UTC

Earnings

DBS 2Q Allowances for Credit, Other Losses S$133.0M Vs. S$148.0M >D05.SG

6 Aug 2025, 22:38 UTC

Earnings

DBS 2Q Net Interest Income S$3.63B Vs. S$3.77B >D05.SG

6 Aug 2025, 22:38 UTC

Earnings

DBS 2Q Total Income S$5.73B Vs. S$5.48B >D05.SG

6 Aug 2025, 22:38 UTC

Earnings

DBS 2Q Net S$2.82B Vs. Net S$2.80B >D05.SG

6 Aug 2025, 22:28 UTC

Market Talk

NZX Bear Says Growth Likely to Miss Market's Hopes -- Market Talk

6 Aug 2025, 22:11 UTC

Earnings

Pan American Silver 2Q Rev $811.90 >PAAS

6 Aug 2025, 22:11 UTC

Earnings

Pan American Silver Raises Dividend to 12c >PAAS

6 Aug 2025, 22:11 UTC

Earnings

Pan American Silver 2Q EPS 52c >PAAS

6 Aug 2025, 22:03 UTC

Earnings

Nutrien 2Q Sales $10.44B >NTR.T

6 Aug 2025, 22:03 UTC

Earnings

Nutrien: Nitrogen Sales Volume Guidance of 10.7MMT to 11.2MMT Assumes Lower Ammonia Operating Rates in 2H Compared to Record Achieved in 1H Due to Planned Turnaround Activity a North Amer Plants >NTR.T

6 Aug 2025, 22:03 UTC

Earnings

Nutrien: Phosphate Sales Volume Guidance of 2.35MMT to 2.55MMT Assumes Improved Operating Rates, Sales Volumes in 2H Compared to Prior Yr With Completion of Planned Turnarounds in 1H >NTR.T

6 Aug 2025, 22:03 UTC

Earnings

Nutrien: Potash Sales Volume Guidance Was Increased to 13.9MMT to 14.5MMT Due to Expectations for Higher Global Demand in 2025 >NTR.T

6 Aug 2025, 22:03 UTC

Earnings

Nutrien 2Q EPS $2.50 >NTR.T

6 Aug 2025, 22:03 UTC

Acquisitions, Mergers, Takeovers

A Family Feud Leaves the Future of This Kefir -2-

6 Aug 2025, 22:03 UTC

Acquisitions, Mergers, Takeovers

A Family Feud Leaves the Future of This Kefir King in Doubt. Danone May Take Over. -- Barrons.com

6 Aug 2025, 22:00 UTC

Market Talk
Earnings

Airbnb 2Q Results Overshadowed by EBITDA Outlook -- Market Talk

6 Aug 2025, 21:53 UTC

Acquisitions, Mergers, Takeovers

Parataxis Holdings: Combines Bitcoin Exposure, Proprietary Growth Opportunities, Accretive Yield Generation >SBXD

6 Aug 2025, 21:53 UTC

Acquisitions, Mergers, Takeovers

Parataxis Holdings: Once Proposed Transaction Is Closed, Combined Co Will Be Named Parataxis Holdings Inc. and Seek to Trade on NYSE Under the Symbol 'PRTX' >SBXD

Peer Comparison

Price change

Phreesia Inc Forecast

Price Target

By TipRanks

17.3% upside

12 Months Forecast

Average 32 USD  17.3%

High 34 USD

Low 29 USD

Based on 9 Wall Street analysts offering 12 month price targets forPhreesia Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

9

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

25.23 / 25.61Support & Resistance

Short Term

Neutral Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Bullish Evidence

Sentiment

By Acuity

76 / 374 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Phreesia Inc

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.